What this video covers
A video from ARDD, posted on Oct 22, 2026. It is about measuring biological age and the science of aging.
It comes from a research institute, foundation or scientific meeting on aging. We link to it; we don't make or endorse it. Research stages on this site come from published studies, not from videos.
Measuring biological age: the research →The science of aging: the research →
From the video's description
Alex Zhavoronkov, Insilico Medicine, presents at the 13th Aging Research and Drug Discovery Meeting: Aging-first Drug Discovery with MMAI and Longevity Foundation Models Key takeaways: – Aging clocks have evolved from “mechanical watches” (early epigenetic clocks) to multi-omic foundation models such as Insilico’s Precious GPT series. – Benchmark of 25,000 prompts across 18 frontier models: smaller fine-tuned models outperformed large LLMs on biological tasks. – Future: large orchestrator models coordinating many specialized agents for continuous research. – AI is validated only when it repeatedly yields successful drug candidates; ~$5M estimated to reach a developmental candidate. The Aging Research and Drug Discovery (ARDD) meeting is the world's leading conference dedicated to longevity biotechnology. It convenes top researchers, pharmaceutical executives, regulators, entrepreneurs,…
Written by ARDD on YouTube.
More videos like this
Research institutePhilipp Gut at ARDD2026: Nutrition to slow biological aging in dogsMeasuring biological age
Research instituteDan Promislow at ARDD2026: The Companion Dog as a Translational Model of AgingRapamycin · Stage 2 of 4
Research instituteKirsten Seale at ARDD2026: From Infrastructure to InsightGLP-1 drugs · Stage 4 of 4
Research instituteKevin Duffin at ARDD2026: Modulation of Aging Clocks by the GLP-1/GIP dual agonist, TirzepatideGLP-1 drugs · Stage 4 of 4